Overview

Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Acute myocardial infarction is generally caused by a thrombotic occlusion of coronary arteries. Primary aim of early therapy is a fast and complete reperfusion of the infarcted myocardium.
Phase:
Phase 3
Details
Lead Sponsor:
Stiftung Institut fuer Herzinfarktforschung
Collaborators:
Daiichi Sankyo Inc.
Daiichi Sankyo, Inc.
Treatments:
Clopidogrel
Prasugrel Hydrochloride
Ticlopidine